https://www.viricabiotech.com/resources/ 2026-08-11T15:49:38+00:00 https://www.viricabiotech.com/resources/the-impact-of-antiviral-defenses-in-viral-vector-production/ 2025-04-30T00:13:57+00:00 https://www.viricabiotech.com/wp-content/uploads/2023/12/White-Paper-The-Impact-of-Antiviral-Defenses-in-Viral-Vector-Production.jpg https://www.viricabiotech.com/resources/increased-aav-yield-from-screen-to-scale-up-to-cost-savings-using-viral-sensitizers-vse-technology/ 2025-04-30T00:14:15+00:00 https://www.viricabiotech.com/wp-content/uploads/2025/03/Virica-Reithera-Poster-Thumbnail.png https://www.viricabiotech.com/resources/viral-sensitizers-unleash-host-cell-potential-to-enhance-aav-production/ 2025-04-30T00:14:42+00:00 https://www.viricabiotech.com/wp-content/uploads/2023/12/ESGCT-2024-Fujifilm_Virica-Poster-Thumbnail.png https://www.viricabiotech.com/resources/evaluation-of-small-molecule-antagonists-of-cellular-innate-immunity-for-t-cell-manufacturing/ 2025-04-30T00:15:19+00:00 https://www.viricabiotech.com/wp-content/uploads/2023/12/Small-Molecule-Antagonists.jpg https://www.viricabiotech.com/resources/harnessing-the-power-of-high-throughput-virology-and-doe-for-rapid-vector-optimization/ 2025-04-30T00:15:49+00:00 https://www.viricabiotech.com/wp-content/uploads/2023/12/DoE-Poster-Graphic.jpg https://www.viricabiotech.com/resources/increased-viral-vector-yield-development-and-scale-up-validation-of-small-molecule-enhancers/ 2025-04-30T00:16:18+00:00 https://www.viricabiotech.com/wp-content/uploads/2024/04/ASGCT-Poster.jpeg https://www.viricabiotech.com/resources/the-impacts-of-suppressing-cellular-innate-immune-responses-on-aav-yields-during-production/ 2025-04-30T00:16:47+00:00 https://www.viricabiotech.com/wp-content/uploads/2023/11/Poster-The-Impacts-of-Suppressing-Cellular-Innate-Immune-Responses-on-AAV-Yields-During-Production.jpg https://www.viricabiotech.com/resources/increase-viral-vector-yield-small-molecule-enhancers-validation-at-multiple-scales/ 2025-04-30T00:17:16+00:00 https://www.viricabiotech.com/wp-content/uploads/2023/11/Poster-Increase-Viral-Vector-Yield-Small-Molecule-Enhancers-Validation-at-Multiple-Scales.jpg https://www.viricabiotech.com/resources/a-novel-approach-to-enhancing-viral-vector-manufacturing-using-small-molecules/ 2025-04-30T00:17:43+00:00 https://www.viricabiotech.com/wp-content/uploads/2023/11/Poster-A-Novel-Approach-to-Enhancing-Viral-Vector-Manufacturing-Using-Small-Molecules.jpg https://www.viricabiotech.com/resources/bioprocess-modelling-of-upstream-viral-vector-production/ 2025-04-30T00:18:10+00:00 https://www.viricabiotech.com/wp-content/uploads/2023/11/Poster-Bioprocess-Modelling-of-Upstream-Viral-Vector-Production.jpg https://www.viricabiotech.com/resources/increasing-vaccine-production-yields-using-small-molecules/ 2025-04-30T00:18:42+00:00 https://www.viricabiotech.com/wp-content/uploads/2024/04/WVC-Poster-Graphic.jpg https://www.viricabiotech.com/resources/modeling-benefits-of-viral-sensitizers-to-increase-virus-production/ 2025-04-30T00:19:32+00:00 https://www.viricabiotech.com/wp-content/uploads/2024/04/ECI-Poster-Graphic.jpg https://www.viricabiotech.com/resources/increasing-aav8-yields-in-the-icellis-nano-bioreactor-using-vse-technology/ 2025-04-30T11:55:39+00:00 https://www.viricabiotech.com/wp-content/uploads/2025/04/Virica-Cytiva-Whitepaper-Thumbnail.png https://www.viricabiotech.com/resources/high-throughput-screening-of-next-generation-small-molecule-enhancers-and-process-automation-in-cloud-connected-bioreactors/ 2025-05-08T23:07:35+00:00 https://www.viricabiotech.com/wp-content/uploads/2023/12/ESGCT-2024_Culture-Poster-Thumbnail.png https://www.viricabiotech.com/resources/optimizing-aav-production-accelerating-discovery-of-small-molecule-enhancers-using-high-throughput-virology-and-design-of-experiments/ 2025-05-10T18:23:26+00:00 https://www.viricabiotech.com/wp-content/uploads/2025/05/Optimizing-AAV-Production_Thumbnail.png https://www.viricabiotech.com/resources/vaccine-vector-production-enhancement-using-small-molecule-vse/ 2025-06-03T17:15:41+00:00 https://www.viricabiotech.com/wp-content/uploads/2025/06/Vaccine-Vector-Production-Enhancement-Using-VSEs-BioSolve-Modelling.png https://www.viricabiotech.com/resources/small-molecule-antagonists-of-cellular-innate-immunity-for-enhanced-cell-and-gene-therapy-manufacturing/ 2025-06-14T11:39:42+00:00 https://www.viricabiotech.com/wp-content/uploads/2025/06/Virica-BSGCT-Poster-Thumbnail.png https://www.viricabiotech.com/resources/rapidly-optimizing-viral-vector-production-without-process-disruption/ 2025-06-19T16:44:03+00:00 https://www.viricabiotech.com/wp-content/uploads/2025/06/Virica-Spring-Digital-Week-Webinar.png https://www.viricabiotech.com/resources/antiviral-defenses-what-you-need-to-know/ 2025-06-19T18:35:09+00:00 https://www.viricabiotech.com/wp-content/uploads/2023/11/Infographic-Thumbnail-AV-Defenses-What-You-Need-to-Know.jpg https://www.viricabiotech.com/resources/closing-the-gaps-in-cell-gene-therapy-manufacturing-with-bioprocess-modelling/ 2025-06-19T18:35:50+00:00 https://www.viricabiotech.com/wp-content/uploads/2023/11/Infographic-Closing-the-Gaps-in-Cell-_-Gene-Therapy-Manufacturing-with-Bioprocess-Modelling.jpg https://www.viricabiotech.com/resources/small-gains-big-wins-how-incremental-yield-increases-drive-major-cost-savings-in-cell-and-gene-therapy-manufacturing/ 2025-06-19T18:38:14+00:00 https://www.viricabiotech.com/wp-content/uploads/2023/12/Biosolve-Gains.jpg https://www.viricabiotech.com/resources/harnessing-the-statistical-power-of-design-of-experiments-to-maximize-viral-vector-biomanufacturing-production/ 2025-06-19T18:38:51+00:00 https://www.viricabiotech.com/wp-content/uploads/2023/12/DoE-HTV-Article-1.jpg https://www.viricabiotech.com/resources/overcoming-the-challenges-of-antiviral-defenses-in-viral-vector-manufacturing/ 2025-06-19T18:39:22+00:00 https://www.viricabiotech.com/wp-content/uploads/2023/12/Article-Overcoming-the-Challenges-of-Antiviral-Defenses-in-Viral-Vector-Manufacturing.jpg https://www.viricabiotech.com/resources/pfizer-paper-production-of-raav-by-plasmid-transfection-induces-antiviral-inflammatory-responses-in-suspension-hek293-cells/ 2025-06-19T18:39:56+00:00 https://www.viricabiotech.com/wp-content/uploads/2023/12/Article-Pfizer-Paper-Production-of-rAAV-by-plasmid-transfection-induces-Antiviral-inflammatory-responses-in-suspension-HEK293-cells.jpg https://www.viricabiotech.com/resources/regulatory-and-scale-up-support-with-you-every-step-of-the-journey/ 2025-06-23T17:46:50+00:00 https://www.viricabiotech.com/wp-content/uploads/2025/06/Regulatory-and-Scale-up-Support-Cover.jpg https://www.viricabiotech.com/resources/purpose-built-vses-for-vpc-2-0-and-fectovir-combination-platforms/ 2025-06-23T17:47:30+00:00 https://www.viricabiotech.com/wp-content/uploads/2025/06/Purpose-Built-VSEs-Thumbnail-Cover.jpg https://www.viricabiotech.com/resources/maximize-viral-yields-with-viricas-curated-vse-library/ 2025-06-23T17:48:20+00:00 https://www.viricabiotech.com/wp-content/uploads/2025/06/Curated-VSE-Library-Cover.jpg https://www.viricabiotech.com/resources/the-virica-advantage-rapidly-maximize-viral-yields-and-cut-production-costs/ 2025-06-23T17:49:12+00:00 https://www.viricabiotech.com/wp-content/uploads/2025/06/Virica-Advantage-Cover.jpg https://www.viricabiotech.com/resources/sustainability-savings-in-vaccine-manufacturing-with-bioprocess-modelling/ 2025-06-27T17:15:42+00:00 https://www.viricabiotech.com/wp-content/uploads/2025/04/Vaccine-Infographic-Thumbnail.png https://www.viricabiotech.com/resources/optimization-of-zika-vaccine-production-using-small-molecule-viral-sensitizers-to-enhance-yields/ 2025-07-17T11:54:52+00:00 https://www.viricabiotech.com/wp-content/uploads/2025/07/Virica-MPI-Paper-Thumbnail.png https://www.viricabiotech.com/resources/optimizing-aav-production-efficiency-a-scalable-approach-using-small-molecule-viral-sensitizers/ 2025-10-02T15:14:07+00:00 https://www.viricabiotech.com/wp-content/uploads/2025/10/Virica-ESGCT-2025-AAV-Poster-Thumbnail.png https://www.viricabiotech.com/resources/enhancing-lentiviral-transduction-efficiency-and-reducing-moi-in-therapeutically-relevant-cell-types-using-small-molecule-viral-sensitizers/ 2025-10-02T15:15:30+00:00 https://www.viricabiotech.com/wp-content/uploads/2025/10/Virica-ESGCT-2025-Transduction-Poster-Thumbnail.png https://www.viricabiotech.com/resources/development-and-scale-up-validation-of-small-molecule-viral-sensitizers-for-increased-vaccine-manufacturing-yields/ 2025-10-02T15:18:07+00:00 https://www.viricabiotech.com/wp-content/uploads/2025/10/Virica-World-Vaccine-Europe-2025-Poster-Thumbnail.png https://www.viricabiotech.com/resources/end-to-end-optimization-of-car-t-manufacturing-boosting-lentiviral-production-and-t-cell-transduction-with-viral-sensitizer-technology/ 2025-10-04T19:21:29+00:00 https://www.viricabiotech.com/wp-content/uploads/2025/05/Virica-ESGCT_2025_Lentivirus-Poster-CAR-T-Manufacturing-Thumbnail.png https://www.viricabiotech.com/resources/virica-brochure/ 2025-11-04T02:16:19+00:00 https://www.viricabiotech.com/wp-content/uploads/2023/11/Virica-Brochure-Thumbnail.png https://www.viricabiotech.com/resources/optimizing-aav-production-efficiency-with-cellvantage-aav-a-simple-scalable-approach-for-enhanced-upstream-yield/ 2026-05-19T18:54:10+00:00 https://www.viricabiotech.com/wp-content/uploads/2025/12/CellVantage-AAV-Poster-Thumbnail-2.png https://www.viricabiotech.com/resources/development-of-small-molecule-enhancer-formulations-for-optimized-aav-production-in-the-elevecta-transient-cell-line/ 2026-05-19T19:21:30+00:00 https://www.viricabiotech.com/wp-content/uploads/2026/05/Virica-eXmoor-Cytiva-AAV-Poster-ASGCT-2026-Thumbnail.png https://www.viricabiotech.com/resources/development-of-small-molecule-enhancers-for-improved-lentiviral-based-cell-therapy-manufacturing-a-niimbl-funded-project/ 2026-05-27T10:51:02+00:00 https://www.viricabiotech.com/wp-content/uploads/2026/05/Virica-LV-Cell-Therapy-NIIMBL-Poster-ASGCT-2026-Thumbnail.png https://www.viricabiotech.com/resources/smarter-lentiviral-vector-manufacturing-for-car-t-higher-productivity-smarter-purification/ 2026-08-11T15:49:38+00:00 https://www.viricabiotech.com/wp-content/uploads/2026/08/Screenshot-2026-08-10-215138.png